 Overall, these symptoms/characteristics are distinguished by prenatal and post-natal overgrowth.Typically, patients identified with SGBS have point mutations or microdeletions in the gene encoding GPC3, and the mutations can occur in multiple different locations of the gene.No correlation has been noticed between the location of the GPC3 mutation and the phenotypic manifestation of this disease.